Research Nester published a report titled “Artificial Intelligence (AI) in Medical Diagnostics Market: Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of theglobal artificial intelligence (AI) in medical diagnostics market in terms of market segmentation by component, application, end-user, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global artificial intelligence (AI) in medical diagnostics market is anticipated to attain a CAGR of ~45% over the forecast period, i.e., 2022 – 2030. The market is segmented on the basis of application into radiology, OBGY, ultrasound, in vitro diagnostic, and others. Out of these, the ultrasound segment is anticipated to hold the notable share over the forecast period on account of growing demand for ultrasound imaging, along with rising adoption of AI for achieving higher accuracy.
The global artificial intelligence (AI) in medical diagnostics market is estimated to grow on the back of growing patient pool at various hospitals, rising prevalence of lifestyle diseases, and increasing health awareness amongst people. Furthermore, rising adoption of artificial intelligence and machine learning is projected to boost the market growth. Moreover, growing demand for early diagnosis of diseases, backed by increasing technological advancement in the healthcare sector, is estimated to boost the market growth.
On the basis of regional analysis, the global artificial intelligence (AI) in medical diagnostics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of technological advancements in healthcare sector in countries, such as, Japan, China, India, and South Korea. Moreover, government initiatives to improve the public healthcare facilities, and rising healthcare expenditure in developing countries, is estimated to boost the market growth.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Increasing Adoption of Artificial Intelligence in Healthcare to Fuel the Market Growth
It is observed that more than 35% of the organizations used artificial intelligence globally, by 2019.
The increasing adoption of AI amongst various end-users, is anticipated to act as the primary growth driver for the market growth. Artificial intelligence provides higher accuracy and efficiency, as it simulates human analysis for treatment and prevention of diseases. Moreover, growing adoption of machine-learning in the healthcare sector, owing to the higher efficiency attained by AI-based diagnosis, is estimated to boost the market growth.
However, the requirement of high initial investment is expected to operate as key restraint to the growth of the global artificial intelligence (AI) in medical diagnostics market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global artificial intelligence (AI) in medical diagnostics market which includes company profiling of HeartFlow, Inc., Therapixel SA, Nano-X Imaging Ltd., Prognos Health Inc., Butterfly Network, Inc., Aidence B.V., Siemens AG, GE Healthcare, Digital Diagnostics Inc., and IBM. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global artificial intelligence (AI) in medical diagnostics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]